Semo, D.; Sidibé, A.; Shanmuganathan, K.S.; Müller, N.; Müller, U.A.; Imhof, B.A.; Godfrey, R.; Waltenberger, J.
Type 2 Diabetes Mellitus Impairs the Reverse Transendothelial Migration Capacity (rTEM) of Inflammatory CD14+CD16− Monocytes: Novel Mechanism for Enhanced Subendothelial Monocyte Accumulation in Diabetes. Cells 2025, 14, 1567.
https://doi.org/10.3390/cells14191567
AMA Style
Semo D, Sidibé A, Shanmuganathan KS, Müller N, Müller UA, Imhof BA, Godfrey R, Waltenberger J.
Type 2 Diabetes Mellitus Impairs the Reverse Transendothelial Migration Capacity (rTEM) of Inflammatory CD14+CD16− Monocytes: Novel Mechanism for Enhanced Subendothelial Monocyte Accumulation in Diabetes. Cells. 2025; 14(19):1567.
https://doi.org/10.3390/cells14191567
Chicago/Turabian Style
Semo, Dilvin, Adama Sidibé, Kallipatti Sanjith Shanmuganathan, Nicolle Müller, Ulrich A. Müller, Beat A. Imhof, Rinesh Godfrey, and Johannes Waltenberger.
2025. "Type 2 Diabetes Mellitus Impairs the Reverse Transendothelial Migration Capacity (rTEM) of Inflammatory CD14+CD16− Monocytes: Novel Mechanism for Enhanced Subendothelial Monocyte Accumulation in Diabetes" Cells 14, no. 19: 1567.
https://doi.org/10.3390/cells14191567
APA Style
Semo, D., Sidibé, A., Shanmuganathan, K. S., Müller, N., Müller, U. A., Imhof, B. A., Godfrey, R., & Waltenberger, J.
(2025). Type 2 Diabetes Mellitus Impairs the Reverse Transendothelial Migration Capacity (rTEM) of Inflammatory CD14+CD16− Monocytes: Novel Mechanism for Enhanced Subendothelial Monocyte Accumulation in Diabetes. Cells, 14(19), 1567.
https://doi.org/10.3390/cells14191567
